BioCryst Pharmaceuticals (BCRX)
(Delayed Data from NSDQ)
$7.15 USD
+0.11 (1.56%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $7.16 +0.01 (0.14%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.17 |
Last EPS Surprise | 26.09% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.66 |
Next Year | -0.36 |
EPS (TTM) | -0.88 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 98.14M | 103.82M | 402.54M | 494.59M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 101.09M | 105.81M | 408.07M | 512.18M |
Low Estimate | 96.58M | 102.36M | 393.51M | 479.06M |
Year ago Sales | 82.49M | 86.74M | 331.41M | 402.54M |
Year over Year Growth Est. | 18.97% | 19.69% | 21.46% | 22.87% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.15 | -0.66 | -0.36 |
# of Estimates | 6 | 5 | 7 | 6 |
Most Recent Consensus | -0.14 | -0.10 | -0.51 | -0.08 |
High Estimate | -0.14 | -0.10 | -0.51 | -0.08 |
Low Estimate | -0.32 | -0.18 | -0.84 | -0.68 |
Year ago EPS | -0.24 | -0.19 | -1.00 | -0.66 |
Year over Year Growth Est. | 20.83% | 21.05% | 34.00% | 46.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.15 | -0.66 | -0.36 |
7 Days Ago | -0.19 | -0.15 | -0.66 | -0.36 |
30 Days Ago | -0.19 | -0.15 | -0.66 | -0.36 |
60 Days Ago | -0.19 | -0.15 | -0.66 | -0.36 |
90 Days Ago | -0.16 | -0.14 | -0.68 | -0.32 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.19 | -0.15 | -0.66 | -0.36 |
Zacks Consensus Estimate | -0.19 | -0.15 | -0.66 | -0.36 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.17 | -0.28 | -0.19 | -0.24 | NA |
Estimate | -0.23 | -0.24 | -0.25 | -0.25 | NA |
Difference | 0.06 | -0.04 | 0.06 | 0.01 | 0.02 |
Surprise | 26.09% | -16.67% | 24.00% | 4.00% | 9.36% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more